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Abstract 
 
Mammalian reproduction is controlled by the hypothalamic-pituitary-gonadal axis. GnRH from 
the hypothalamus regulates synthesis and secretion of gonadotropins, LH and FSH, which then 
control steroidogenesis and gametogenesis. In females, serum LH and FSH levels exhibit 
rhythmic changes throughout the menstrual or estrous cycle that are correlated with pulse 
frequency of GnRH. Lack of gonadotropins leads to infertility or amenorrhea. Dysfunctions in 
the tightly controlled ratio due to levels slightly outside the normal range occur in a larger 
number of women and are correlated with polycystic ovaries and premature ovarian failure. 
Since the etiology of these disorders is largely unknown, studies in cell and mouse models may 
provide novel candidates for investigations in human population. Hence, understanding the 
mechanisms whereby GnRH regulates gonadotropin hormone levels will provide insight into the 
physiology and pathophysiology of the reproductive system. This review discusses recent 
advances in our understanding of GnRH regulation of gonadotropin synthesis.  
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1. Physiology and pathophysiology of LH and FSH 
Gonadotropin hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) 
are synthesized by the anterior pituitary gonadotropes and secreted into the circulation to 
regulate gonadal function. Every secretory pulse of LH from the pituitary corresponds to a pulse 
of GnRH from the hypothalamus (Levine et al., 1982). On the other hand, FSH secretion is not 
entirely regulated by GnRH and most of FSH is constitutively released (Culler and Negro-Vilar, 
1987; Levine and Duffy, 1988). In females, LH and FSH concentration fluctuates throughout the 
menstrual or estrous cycle and the levels are firmly controlled to assure reproductive fitness and 
new waves of steroidogenesis and gametogenesis (Pierce, 1988). Pulsatile LH secretion 
maintains basal level of this hormone in the circulation and steroidogenesis throughout the cycle. 
LH increases steroid hormone production via induction of steroidogenic enzymes in interstitial 
Leydig cells and theca cells in males and females, respectively. In females, LH exhibits a 5-10 
fold mid-cycle increase that causes ovulation. FSH in males induces androgen binding protein 
and contributes to spermatogenesis through interaction with testosterone. In females, FSH 
stimulates aromatase expression in follicle granulosa cells, which increases estrogen production 
and follicular growth. FSH increases together with LH during the preovulatory surge and 
exhibits a separate, second increase that is necessary for folliculogenesis.  
LH and FSH are critical for reproductive fitness and thus, survival of the species. LH is 
required for pubertal development and gonadal function, and a lack results in hypogonadism and 
infertility in both sexes in humans and mouse models (Huhtaniemi, 2006; Huhtaniemi et al., 
2006; Ma et al., 2004). FSH in humans is also critical for reproductive function in both genders, 
since its deficiency results in absent or incomplete pubertal development in women, relatively 
normal pubertal development but azoospermia in men, and infertility in both women and men 
(Lamminen et al., 2005). Female mice deficient in FSH have a block in folliculogenesis prior to 
the antral stage resulting in infertility, while males have impaired reproductive function due to 
lower sperm count, but are not infertile (Kumar et al., 1997).  
LH and FSH are glycoprotein heterodimers, each comprised of a common α subunit 
(Cga, or αGSU) and a unique β subunit (Pierce and Parsons, 1981). αGSU is minimally regulated 
by hormones, since it is expressed at the sufficiently high basal level (Chin and Boime, 1990). 
Unique β-subunits provide biological specificity and are limiting components in the mature 
hormone synthesis, whose amounts are regulated at the transcriptional level of the β-subunits 
(Kaiser et al., 1997b; Papavasiliou et al., 1986). Pulsatile GnRH secretion increases transcription 
of LHβ subunit (Burger et al., 2009; Haisenleder et al., 2008; Haisenleder et al., 1988).  
Although FSH can be secreted without a corresponding GnRH pulse, FSHβ transcription is 
dependent on GnRH. In mice lacking GnRH (Mason et al., 1986) or GnRH receptor (Wu et al., 
2010), FSH levels, as well as LH levels, are 60%-90% lower in males and females.  GnRH 
injection in rats with low endogenous GnRH increased FSH transcription 4 fold (Dalkin et al., 
2001).  This level of increase is comparable to the changes in FSH concentration in the 
circulation throughout the cycle. Therefore, while concentration of LH in the circulation is 
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regulated at both the level of β subunit transcription and GnRH-stimulated secretion, FSH 
concentration is regulated primarily at the level of β subunit transcription. Regulation of 
gonadotropin synthesis and differential expression is not elucidated at the mechanistic level. 
Herein, we discuss recent findings since our previous review (Thackray et al., 2010), 
concentrating on the regulation of β-subunit transcription by GnRH. Our review may shed light 
on differential regulation and point to remaining gaps in our knowledge, providing basis for 
future investigations that may lead to novel therapeutic treatments of reproductive disorders 
discussed below. 
1.1. Differential regulation of LH and FSH synthesis  
Both gonadotropins are synthesized in the same gonadotrope cells, but differences in the 
relative amounts occur at specific stages of the menstrual or estrous cycle. As illustrated above, 
LH exhibits a single increase during the preovulatory surge, while FSH increases two times 
during the menstrual or estrous cycle. The question of how are these two hormones differentially 
regulated in the same gonadotrope population, by the same hormonal milieu, has been an area of 
intense investigation. Differential levels of LH and FSH may stem from differences in secretion, 
since LH is secreted strictly through the GnRH-regulated secretory pathway while FSH is 
constitutively secreted (Levine and Duffy, 1988).  
Alternatively, post-translational modifications of these hormones contribute to 
differences in the half-life that would ultimately affect concentration in the circulation. Namely, 
LH and FSH are N-linked glycosylated proteins, containing N-acetylglucosamine residue linked 
to an amide group of an asparagine (Asn) amino acid in the peptide chain (Green et al., 1986). N-
linked glycosylation of LH and FSH is critical for their bioactivity and non-glycosylated forms 
serve as antagonists (Fares, 2006). This is likely due to necessity of glycosylation for 
dimerization of α and β subunits and subsequent glycohormone secretion (Wang et al., 2016). 
LH and FSH have many molecular variants depending on the differences in their oligosaccharide 
chains. Alkalinity/acidity of variants, and their half-life in the circulation, depends in part on 
sialylation and sulfation of terminal galactose. There is a shift to less basic variants of LH at the 
evening of proestrus and to more basic variants of LH after ovariectomy (De Biasi et al., 2002), 
while FSH is shifted to less acidic variant at midcycle (Wide and Bakos, 1993), implying 
endocrine regulation of glycosylation enzymes’ activity (Damian-Matsumura et al., 1999; Ulloa-
Aguirre et al., 2001). Furthermore, human FSH is primarily siaylated while LH is sulfated, a 
difference that contributes to their variable clearance rates (Green et al., 1986). Since the enzyme 
that adds the sulfate, sulfotransferase, does not recognize specific peptide sequence but requires 
only tri-saccharides (Ulloa-Aguirre et al., 1999), enzyme synthesis or activity represents another 
layer of potential differential regulation of gonadotropin hormones synthesized in the same cell.  
Lastly, β-subunit transcription precedes changes in hormone concentration in the 
circulation, and fluctuations in mRNA levels in the gonadotrope correlate with concentration of 
the hormones. Therefore, transcriptional regulation of β-subunits may be a critical point that 
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determines levels of gonadotropin hormones. A midcycle surge of GnRH elicits a surge in both 
LH and FSH, resulting in ovulation of the mature follicle in response to LH (Jones, 1997). LHβ 
gene is induced five fold and FSHβ transcription increases four fold in the afternoon of proestrus 
prior to the onset of the surge (Butcher et al., 1974; Ortolano et al., 1988; Zmeili et al., 1986). In 
rodents, during the morning of estrus, a secondary FSH raise occurs without a concomitant 
increase in LH (Besecke et al., 1997; Woodruff et al., 1996). FSHβ mRNA is induced three fold 
during this time (Halvorson et al., 1994; Ortolano et al., 1988). This secondary increase in FSH 
is essential for follicular development for the subsequent estrous cycle (DePaolo et al., 1979; 
Hoak and Schwartz, 1980; Papavasiliou et al., 1986). In humans, the FSH levels in the serum 
increase in the late luteal phase through the mid follicular phase of the menstrual cycle. This 
FSH increase corresponds to a time when the next cohort of follicles is being recruited during 
folliculogenesis. Thus, although responding to the same hormonal milieu, synthesis of LH and 
FSH is differentially regulated during the estrous or menstrual cycle and this regulation appears 
to occur primarily at the level of the β subunits transcription. This differential expression of two 
gonadotropin hormones from the same cell in response to the same endocrine stimuli is critical 
for reproductive fitness. 
1.2. Polycystic ovary syndrome (PCOS) 
Higher than normal levels of gonadotropins in females also lead to reproductive 
pathologies, albeit less severe than a lack of hormone. Most notably, polycystic ovary syndrome 
(PCOS) is characterized by an increase specifically in LH (Chang, 2007; Hall et al., 1998; 
Morales et al., 1996), and premature ovarian failure (POF) or primary ovarian insufficiency is 
associated with an increase in FSH (Chand et al., 2010; Goswami and Conway, 2007). The 
etiology of PCOS and POF is not clear; it may stem from dysregulation of GnRH pulsatility, 
pituitary responsiveness, or ovarian hormone production. Endocrine feedback loops cause 
difficulty in pin-pointing the primary site of dysregulation.  
PCOS affects 10% of reproductive age women, yet much is unknown regarding the cause 
and pathophysiology (De Leo et al., 2016). This is complicated by the fact that the syndrome is 
categorized with heterogeneous characteristics and patients present with a combination of several 
symptoms such as chronic or frequent anovulation, polycystic ovaries, hyperandrogenism, 
hirsutism, acne, obesity, and insulin resistance (Goodarzi et al., 2011). Elevated LH levels are 
observed in 55%-75% of the women with PCOS, leading to elevated LH/FSH ratio (De Leo et 
al., 2016).  Since obesity is often comorbid with PCOS, and obesity causes reduced LH levels 
(Mihalca and Fica, 2014; Pasquali et al., 2002; Rosenfield and Bordini, 2010), PCOS women 
with normal LH levels may have competing influences of obesity and PCOS per se, that keep the 
LH within the normal range. In a support of this supposition, lean PCOS patients have elevated 
LH levels (Pangaribuan et al., 2011; Sahin et al., 2014). Recent genomic studies correlated 
polymorphism in the LHβ gene to the occurrence of PCOS (El-Shal et al., 2016), implicating 
dysregulation in LHβ transcription, and possibly higher LH levels, among the causes of PCOS. 
Surprisingly, another genome wide association study correlated polymorphism in FSHβ promoter 
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with PCOS, implicating changes in FSH levels with this disorder, maybe through altered 
estrogen synthesis (Hayes et al., 2015).  
Preponderance of animal studies point to prenatal or early hyperandrogenemia as a 
contributing cause of PCOS (Abbott et al., 2008; Abbott et al., 2013; Kauffman et al., 2015; 
Manikkam et al., 2008; Roland et al., 2010; Veiga-Lopez et al., 2008). High insulin levels, with 
or without obesity, in PCOS patients may be a cause of hyperandrogenimia since insulin in 
synergy with LH elicits ovarian androgen production (recently reviewed in (Rosenfield, 2013)).  
Subsequently, hyperandrogenemia may diminish progesterone inhibition of GnRH pulse 
frequency, causing rapid pulsatile secretion of LH and further increase in ovarian androgen 
production, correlating regulation of LH frequency and amplitude to PCOS (Moore et al., 2015; 
Pielecka et al., 2006).  
1.3. Premature ovarian failure (POF) 
Premature ovarian failure (POF) or primary ovarian insufficiency is a disorder affecting 
1% of reproductive age women that lose ovarian function before the age of 40. Majority of POF 
cases are idiopathic, while 10% are acquired due to chemotherapy, autoimmunity, or toxicity, 
and 20% have known genetic causes (Rossetti et al., 2016). Fragile X mutation or pre-mutation 
carriers comprise a bulk of individuals with known genetic causes of POF (Macpherson and 
Murray, 2016).  The rest have mutations in autosomal genes, such as FOXL2, FSH receptor, 
aromatase and others, which were associated with POF (Laven, 2016).  
However, as mentioned, in 70% of patients POF is idiopathic. They are diagnosed usually 
after ovarian function has ceased, since they seek care due to infertility or amenorrhea. At that 
time it is not clear if increased FSH stems from a deficiency in ovarian inhibin and is the result 
of a lack of negative feedback, or if increased FSH was a contributing factor (Laven, 2016). 
Thus, there is disagreement whether the high FSH level in POF is preceded by diminished 
ovarian inhibin level; or alternatively, high FSH leads to recruitment of larger number of follicles 
into a growing pool in every cycle in younger women resulting in early depletion. In the Fragile 
X syndrome mouse model, FSH is elevated prior to the loss of ovarian function, strengthening 
the possibility that high FSH may be a cause and not a consequence (Lu et al., 2012). Recently, it 
was determined that increased levels of FSH in the circulation in other mouse models, due to 
overexpression or re-trafficking of FSH to the GnRH-regulated secretory pathway, resulted in 
hemorrhagic ovaries and 5-fold more corpora lutea, implicating higher FSH levels in greater 
follicle recruitment (Kumar et al., 1999; Wang et al., 2014). Mouse model of constitutively 
active FSH receptor also experiences accelerated loss of follicular reserves (Peltoketo et al., 
2010). Furthermore, polymorphism in the human FSHβ promoter, which regulates β subunit 
expression, increases FSH levels and has been associated with early menarche and premature 
menopause in women (He et al., 2010). Another genome-wide association study reported that 
polymorphism in the 5’ region of the FSHβ gene is also associated with higher FSH levels in the 
circulation, premature puberty, early natural menopause, and dizygotic twinning (Mbarek et al., 
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2016).  
Therefore, although feedbacks complicate pin-pointing the primary site of dysregulation, 
genomic evidence ties polymorphism in the FSHβ gene promoter to POF, indicating that 
regulation of FSHβ subunit expression may contribute significantly to the etiology, at least in 
some affected individuals.  Alternatively, mutations in transcription factors that influence FSHβ 
transcription, such as FOXL2, or signaling pathways that lead to induction of FSHβ mRNA may 
contribute to POF. Given that 70% of POF patients develop this disorder from unknown causes, 
studies using mouse models or model cell lines, may provide potential candidates to investigate 
etiology in human population. 
 
 
2. GnRH receptor signaling pathways that regulate gonadotropin gene expression 
The complexity of GnRH signaling provides a variety of regulatory avenues for 
gonadotropin gene regulation (Fig. 1). Molecular studies that identified signal transduction 
pathways activated by GnRH receptor (GnRHR) binding have been facilitated with the 
development of model cells lines. Whole animal studies, although critical for understanding of 
the HPG axis within the endogenous hormonal setting, can be inconclusive as illustrated above, 
due to hormonal feedback and the possible effects on different levels of the axis. Primary 
pituitary cells are frequently employed to study hormonal effects on gonadotropin synthesis. 
However, they are not conducive to analyses at the molecular levels due to scarcity of 
gonadotropes that comprise around 10% of the mixed cells population in the anterior pituitary.  
Two immortalized clonal cell lines were developed in the Mellon laboratory using targeted 
tumorigenesis with SV40 T-antigen, which contributed greatly to delineating GnRH signaling 
pathways and transcriptional regulation of β-subunits (Alarid et al., 1998; Alarid et al., 1996). 
The αT3-1 cell line created using the 5’ regulatory regions of α-GSU approximates an immature 
gonadotrope cell. It expresses α-GSU and GnRH receptor, but not β-subunits. On the other hand, 
the LβT2 cell line created using LHβ promoter, displays a more mature phenotype since it 
expresses LHβ and FSHβ and secretes LH and FSH in response to hormonal cues (Graham et al., 
1999; Pernasetti et al., 2001).  
Because it may underlie molecular causes of subfertility, pituitary responsiveness to 
GnRH leading to induction of gonadotropin expression is an important area of investigation. 
GnRH binding to its G protein-coupled receptor (GPCR), expressed on the gonadotropes of the 
anterior pituitary, activates the synthesis of the gonadotropin hormones, LH and FSH, and 
stimulates their secretion (Seeburg et al., 1987; Vale et al., 1977).  GnRH is secreted in a 
pulsatile fashion into the hypophysial-portal system, while long-term tonic exposure to GnRH 
adversely affects gonadotrope function (Belchetz et al., 1978; Burrin and Jameson, 1989; 
Shupnik, 1990). Frequency of GnRH pulses changes throughout the menstrual and estrous cycle, 
modulated by the upstream regulatory neuronal network. Kisspeptin, secreted by several 
neuronal populations, is a crucial neuropeptide that synchronizes GnRH neuron secretion and 
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stimulates GnRH release (Semaan and Kauffman, 2010). GnRH exhibits high pulse frequency in 
proestrus during the preovulatory surge (Harris and Levine, 2003; Levine et al., 1985; Levine 
and Ramirez, 1982). Several seminal studies analyzing β subunits transcription in the rat in vivo 
determined that fast pulse frequency of GnRH favors LHβ synthesis, while FSHβ expression is 
more highly induced by low pulse frequency (Burger et al., 2002; Dalkin et al., 1989; 
Haisenleder et al., 1991; Kaiser et al., 1997b; and recently reviewed in Thompson and Kaiser, 
2014). However, the mechanisms of gonadotrope responsiveness to varied pulse frequencies are 
only beginning to emerge.  
Although a member of the G protein-coupled seven transmembrane domain receptors, 
GnRHR has a unique structure (Neill, 2002; Tsutsumi et al., 1992).  Unlike the other family 
members, it lacks the intracellular carboxyl-terminal tail and contains several sequence 
differences in regions otherwise highly conserved (Kaiser et al., 1997a; Sealfon et al., 1997; 
Stojilkovic et al., 1994; Tsutsumi et al., 1992). The absence of the C-terminal tail that normally 
mediates desensitization through β-arrestin association and encapsulation into clathrin-coated 
vesicles renders the receptor resistant to this regulatory mechanism. Thus, the receptor does not 
internalize as rapidly as other GPCRs (Blomenrohr et al., 1999; Hislop et al., 2001; McArdle et 
al., 2002; Pawson et al., 2008; Willars et al., 1999), leading to longer signaling, which raises a 
question of intracellular negative feedback that stops the signal. Since gonadotropin gene 
expression is dependent upon GnRH pulses, the gonadotropes must maintain sensitivity to 
subsequent GnRH pulses by resolving the effect of a prior pulse. Several steps of the GnRH 
signaling pathways therefore contain negative regulators, in addition to molecules that propagate 
the signal, which will be discussed below. This rapid adaptation and maintenance of 
responsiveness underlies the ability of gonadotropes to properly express LH and FSH and 
regulate reproductive function.  
2.1. G-proteins 
Ligand binding to the GnRHR causes activation of trimeric G proteins. Gαq/11 isoform is 
activated in a model of immature gonadotrope, αT3 cells, while both Gαq/11 and Gαs are 
involved in GnRHR signaling in a model of mature gonadotrope LβT2 cells and in primary rat 
cultures. Some involvement of Gαi and Gα12/13 was shown as well, but without a clear 
downstream effect (Liu et al., 2002; Liu et al., 2003; Naor et al., 2000; Sim et al., 1995; 
Stanislaus et al., 1998).  GnRHR coupling to various G proteins has been reviewed of late (Naor 
and Huhtaniemi, 2013) and it won’t be discussed in depth here. Although GnRH signaling has 
been reviewed recently as well (Perrett and McArdle, 2013), in this review we will focus on how 
these various signaling pathways and downstream effectors contribute to differential expression 
of gonadotropin β subunits.  
Recently the functional significance of activation of Gαq/11 and Gαs trimeric G proteins 
by GnRH was assessed in LβT2 using siRNA. The study demonstrated that endogenous FSHβ 
mRNA induction requires Gαq/11, while maximal LHβ involves Gαs (Choi et al., 2012). 
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Surprisingly, Gαs activity may diminish FSHβ expression, via induction of inhibin α (Choi et al., 
2012).  Thus, engagement of either Gαq/11 or Gαs may lead to differential expression of 
gonadotropin β subunits.  
Activation of Gαs normally leads to cAMP-PKA signaling, but downstream targets of 
this pathway at the level of the LHβ promoter are unknown. Elegant study by Webster lab 
demonstrated that GnRH signal has a unique kinetics of cAMP generation and PKA activation 
compared to other stimuli that activate the same pathway (i.e. Pituitary adenylate cyclase-
activating polypeptide (PACAP, (Tsutsumi et al., 2010)). More importantly, the study 
demonstrated that Gαs-cAMP-PKA module is not susceptible to desensitization (Tsutsumi et al., 
2010).   
More commonly, GnRHR couples to Gαq/11 and activates phospholipase Cβ (PLC), 
causing a creation of inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG; Stojilkovic et 
al., 1994). IP3 formation and IP3 receptor activation leads to an increase in intracellular calcium 
concentration via calcium mobilization from intracellular stores. Increase in DAG and 
intracellular calcium concentration leads to activation of PKC and calcium calmodulin kinase II 
(CamKII), respectively. Gαq/11-PLC-DAG/Calcium signaling module desensitizes at several 
steps after GnRH stimulation: at DAG generation and at calcium increase (Tsutsumi et al., 
2010). The latter may be due to the loss of IP3 receptors via downregulation that are necessary 
for calcium mobilization (McArdle et al., 1999; McArdle et al., 2002; McArdle et al., 1996). 
Thus, fast pulse frequency of GnRH from the hypothalamus may desensitize Gαq/11-DAG and 
lead to lower FSHβ expression, while Gαs does not desensitize and leads to increased LHβ. The 
question whether Gαs signal is less sensitive or not sustained during low pulse frequency, which 
results in lower LHβ than FSHβ needs to be elucidated. It has been postulated that GnRH may 
switch to Gαs-cAMP signal only during preovulatory surge to engage new set of signaling 
targets (Lariviere et al., 2007). Indeed, fast pulse frequency increases receptor concentration on 
the cell surface (Bedecarrats and Kaiser, 2003).  This higher receptor number may allow 
coupling to and engaging Gαs in addition to Gαq/11, which induces higher levels of LHβ 
necessary for a rapid increase of LH in the circulation and ovulation, while low pulse frequency 
and Gαq/11 activation may be sufficient for lower level of LHβ induction, as well as FSHβ, 
throughout the rest of the cycle to stimulate steroidogenesis and folliculogenesis (Fig. 2). 
2.2. Calcium 
GnRH receptor activation causes an increase in intracellular calcium concentration. The 
calcium increase stems either from mobilization from intracellular calcium stores or from influx 
through the calcium channels (Mulvaney et al., 1999; Van Goor et al., 1999); recently reviewed 
in (Stojilkovic, 2012; Stojilkovic et al., 2010). As discussed above, increase in calcium from 
intracellular stores occurs through IP3 formation, and is sensitive to desensitization via 
downregulation of IP3 receptors (McArdle et al., 1999; McArdle et al., 2002; McArdle et al., 
1996). Consistent with this, using αT3 cells, it was demonstrated that extracellular calcium influx 
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leads to more sustained increase in calcium than mobilization from intracellular stores 
(Mulvaney and Roberson, 2000). Calcium channels may be activated by GnRH through PKC 
(Stojilkovic et al., 1991). Pulsatile stimulation of the calcium channel by a pharmacological 
activator in the rat pituitary cells exhibits the same effect on the gonadotropin gene expression as 
GnRH pulses, with higher pulse frequencies favoring LHβ transcription, and lower pulse 
frequencies preferring FSHβ transcription (Haisenleder et al., 2001).  
Increase in calcium concentration activates CamKII, and CamKII is activated by GnRH 
irrespective of pulse frequency (Burger et al., 2008) and plays a role in induction of both β-
subunits (Ely et al., 2011; Haisenleder et al., 2003b).  Consistent with a lack of frequency 
dependence, CamKII activation can be achieved with either source of calcium, extracellular or 
from internal stores in LβT2 cells (Haisenleder et al., 2003b). Nuclear factor of activated T-cells 
(NFAT) is another putative target of calcium increase via calciuneurin that may be activated by 
GnRH to induce immediate early gene promoters (Binder et al., 2012). Calcium causes 
calmodulin/calcineurin-dependent nuclear NFAT translocation, but a lack of desensitization of 
this pathway implies that while NFAT may mediate GnRH action, it is not a decoder of GnRH 
pulse frequency (Armstrong et al., 2009). Additionally, the effect of NFAT on gonadotropin β-
subunit expression has not been demonstrated. Thus, CamKII maybe a critical signaling 
molecule activated by calcium. 
2.3. MAPK 
GnRHR ligand binding also leads to activation of three branches of the mitogen-activated 
protein kinase (MAPK) pathway: ERK1/2, JNK, and p38 (Liu et al., 2002; Roberson et al., 1995; 
Sundaresan et al., 1996). Mechanisms of MAPK activation are not completely clear. GnRHRs 
are found in low-density membrane microdomains called lipid rafts, which are enriched in 
cholesterol and sphingolipids and may allow assembly of multiprotein signaling complexes 
(Navratil et al., 2003).  In αT3 cells and mouse pituitary cells, GnRHRs co-localize with a 
proportion of total cellular ERK2 in lipid rafts (Bliss et al., 2007), which may provide a partial 
explanation of ERK2 activation by GnRH. Activation of ERK1/2 by GnRH also involves 
calcium. ERK1/2 responds to pulsatile GnRH, and lower pulse frequency leads to longer, 
sustained activation in LβT2 mature gonadotrope cell line, which may correlate ERK1/2 
activation to FSHβ expression (Kanasaki et al., 2005). Additionally, low pulse frequency of 
GnRH causes high amplitude of ERK1/2 activation that is necessary for FSHβ transcription in 
vivo in rats (Burger et al., 2008; Haisenleder et al., 1998). Extracellular calcium influx through 
voltage gated calcium channel may be necessary for ERK1/2 activation in αT3 cells (Mulvaney 
et al., 1999). The study demonstrating that PKC stimulation leads to voltage gated calcium 
channel activation (Stojilkovic et al., 1991), may explain why ERK1/2 phosphorylation is PKC 
dependent (Ely et al., 2011). However, ERK1/2 solely may not be a true frequency decoder due 
to different kinetics of activation and deactivation (Armstrong et al., 2010). The mathematical 
model postulated by this group (Armstrong et al., 2011) implies cooperative action of two or 
more pathways leading to two or more transcription factors that coordinately induce the 
 12 
expression of their target gene.  
The p38 branch of the MAPK pathway is also activated by GnRH via PKC and calcium 
(Mugami et al., 2017; Roberson et al., 1999). p38 can be activated by both extracellular calcium 
influx and from intracellular stores in αT3 cells, while in LβT2 p38 activation requires calcium 
from intracellular stores. Pulse dependency of p38 activation has not been analyzed. p38 
activation is involved in FSHβ induction by GnRH in LβT2 cells (Bonfil et al., 2004; Coss et al., 
2007; Ely et al., 2011; Wang et al., 2008), but it is not critical in vivo in rats (Haisenleder et al., 
2008). Calcium from intracellular stores leads to JNK activation in αT3 cells (Kraus et al., 2001; 
Mulvaney and Roberson, 2000). Whether these distinct calcium sources: extracellular, leading to 
ERK1/2 activation and intracellular, leading to JNK activation play a role in more mature LβT2 
cells or primary gonadotrope as well is yet to be determined. GnRH activation of ERK1/2, p38 
and JNK involves several PKC isoforms in both αT3 and LβT2 cells, primarily PKC, PKC 
and PKC (Dobkin-Bekman et al., 2010; Kratzmeier et al., 1996; Liu et al., 2003; Mugami et al., 
2017). However, a specific isoform which selectively activates ERK1/2 but not JNK has not 
been identified, to indicate the isoform necessary for voltage gated calcium channel activation 
and extracellular calcium influx. Furthermore, understanding of the significance of the studies 
delineating Gαs versus Gαq/11 signaling modules is complicated by findings that these same 
PKC and PKC that are normally activated by Gαq/11 maybe be involved in cAMP 
accumulation, in addition to cAMP accumulation by Gαs activation (Lariviere et al., 2007). More 
importantly, PKC isoform-specific roles in gonadotropin gene expression were not examined.   
While ERK1/2 may be activated longer or more highly with low pulse frequency of 
GnRH, regulation of MAPK activity occurs at the level of dephosphorylation as well. MAPKs 
are deactivated by a family of MAPK phosphatases (MKPs), which is a subfamily of a large 
dual-specificity phosphatase (DUSP) family.  Studies analyzing MPKs/DUSPs are complicated 
due to multiple members that are ubiquitously expressed and lack substrate specificity. 
MKP1/DUSP1 and MKP2/DUSP4 are induced by GnRH in αT3 cells (Roberson et al., 1995; 
Zhang and Roberson, 2006). MKP1/DUSP1 is also phosphorylated by GnRH and, since 
localized specifically in the nucleus, it may provide rapid cessation of nuclear ERK1/2 activity 
specifically and maintain sensitivity to GnRH stimulation. (Nguyen et al., 2010). MKP1/DUSP1 
is induced with high pulse frequency of GnRH (Purwana et al., 2011), which may explain 
sustained ERK1/2 activation with low pulse frequency.  
In summary, GnRH-stimulated calcium increase from two different sources, 
intracellular stores or extracellular influx, activates different downstream signaling pathways. 
Since one of them, intracellular via IP3, can be desensitized, calcium sources may lead to 
differential regulation of downstream gene targets; however this remains to be examined. 
Receptor concentration may also play a role. Fast pulse frequency leads to higher receptor 
concentration, which is correlated to higher LHβ transcription. Therefore, at low pulse 
frequency, GnRHR couples to Gαq/11 and activates CamKII that induces both LHβ and FSHβ 
transcription. Activation of PKC additionally causes influx of extracellular calcium, which leads 
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to sustained activation of ERK1/2 and preferential induction of FSHβ to a higher level than LHβ. 
At high pulse frequency, GnRHR number is augmented, and this high receptor number allows 
for coupling to both Gαs and Gαq/11, and while Gαq/11 desensitizes, sustained signaling via 
Gαs module induces higher expression of LHβ via unknown mechanism (Fig. 2).  
 
 
3. GnRH regulation of LHβ and FSHβ Transcription  
The specific gonadotropin β subunits are expressed at low basal levels and are 
differentially induced through pulses of GnRH (Bedecarrats and Kaiser, 2003; Haisenleder et al., 
1991; Shupnik, 1996; Weiss et al., 1990). GnRH regulates expression of the specific β subunits 
through immediate-early genes. Early growth response 1 (EGR1) is an intermediary gene that 
regulates GnRH induction of LHβ, while activating protein 1 (AP1) transcription factor, 
comprised of a heterodimer of FOS and JUN isoforms, mediates induction of FSHβ by GnRH 
(Fig. 3).  
3.1. GnRH regulation of LHβ transcription 
Immediate-early gene that regulates LHβ induction by GnRH is EGR1 and is the only 
transcription factor binding the LHβ promoter that is dramatically induced by GnRH (Tremblay 
and Drouin, 1999). EGR1 is the most highly induced gene in the gonadotrope by GnRH in LβT2 
model of mature gonadotrope when analyzed by microarrays (Kakar et al., 2003; Lawson et al., 
2007; Wurmbach et al., 2001). EGR1 is also induced in rat primary pituitary cells following 
GnRH stimulation (Kucka et al., 2013). Confirming a role of EGR1 and lack of compensation by 
other family members (EGR2, EGR3, and EGR4), the EGR1 null mice are infertile and lack 
expression of the LHβ gene (Lee et al., 1996). EGR1 also organizes a complex on the LHβ 
promoter to bring forth coordinated expression of this gene. In the proximal LHβ promoter 
region, two EGR1 sites are located adjacent to sites for steroidogenic factor 1 (SF1; or NR5A1) 
on either side of a homeodomain element (HD) bound by Ptx1 (Halvorson et al., 1996; Quirk et 
al., 2001). This location allows for a complex formation that integrates pituitary specific (SF1), 
basal (Ptx1) and GnRH-induced (EGR1) expression. Synergistic interaction between SF1, EGR1 
and Ptx1 is essential for maximal LHβ gene expression (Dorn et al., 1999; Tremblay and Drouin, 
1999). EGR1-organized complex interacts with the Sp1 sites in the distal region (Kaiser et al., 
1998), in a spatially-dependent manner (Kaiser et al., 2000; Weck et al., 2000). Interaction is 
likely facilitated by the co-activators, SNURF (Curtin et al., 2004) and p300 (Mouillet et al., 
2004). β-catenin may play a role in GnRH induction of LHβ via interaction with this complex 
through SF-1 (Gardner et al., 2007; Salisbury et al., 2007). However, recent studies addressing a 
role of β-catenin in the gonadotrope in vivo demonstrated a lack of any role for β-catenin in LHβ 
expression and LH levels in the circulation, in either gonadotrope specific deletion of β-catenin, 
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or gonadotrope specific stabilization of β-catenin, which increases its levels in the cell 
(Boerboom et al., 2015). 
 Mechanisms involved in the responsiveness to pulsatile GnRH treatment and frequency-
dependent expression of the LHβ gene have also been analyzed. Namely, maximal LHβ 
expression is achieved with high pulse frequency characteristic of pre-ovulatory period. This 
allows for a high level of LHβ gene expression, which then dimerizes with non-limiting α-
subunit and during preovulatory surge of GnRH increases rapidly LH levels in the circulation 
that are necessary for ovulation. EGR1 intermediate gene which induces LHβ in response to 
GnRH, similarly to other immediate early genes, is not only rapidly activated, but is rapidly 
degraded as well.  The short half-life allows for strong temporal regulation of gene targets. To 
address the importance of pulsatile GnRH treatment, it was postulated that proteasome function 
is critical for LHβ responsiveness to GnRH treatment, since GnRH leads to ubiquitination of 
EGR1 and cycling of this factor on and off of the LHβ promoter (Walsh and Shupnik, 2009). 
Cycling of EGR1 may explain the importance of pulsatile GnRH compared to tonic treatment 
that inhibits gonadotropin expression. 
Explanation of higher induction with high pulse frequency of GnRH characteristic of the 
preovulatory proestrus period, may lie in the differential expression of intermediates. High pulse 
frequency upregulates SF1 mRNA in rat pituitary cells (Burger et al., 2011), which, although 
SF1 induction is much lower than of EGR1, combined with already high basal level, is sufficient 
to form a complex with highly induced EGR1 with any frequency. Another mechanisms is 
differential regulation of positive and negative regulators of transcription. Sustained induction of 
EGR1 specific repressor proteins from the Nab family at low pulse frequency may explain the 
necessity for high pulse frequency of GnRH for LHβ responsiveness (Lawson et al., 2007). High 
pulse frequency of GnRH may be necessary to allow for accumulation of EGR1 protein in order 
to overcome repression by Nabs. 
As mentioned previously, β-subunits are expressed at a very low basal level which may 
indicate active repression until a signal is applied that would de-repress the promoter at the 
appropriate time. Repressors that bind inactive promoters normally function via recruitment of 
histone deacetylase (HDAC) enzymes that remove active histone acetylation marks and prevent 
transcription. GnRH stimulus leads to changes in histone acetylation in the αT3 model of 
immature gonadotrope that normally do not express β-subunits (Lim et al., 2007). This may 
designate developmental activation of β-subunit transcription via chromatin remodeling, which 
occurs after gonadotropes acquire responsiveness to GnRH. Developmental and prepubertal 
regulation of gonadotropin subunits by GnRH is supported by a recent thorough study that 
demonstrated strong correlation and synchronization of GnRHR expression with gonadotropin β-
subunit expression in female and in male rats (Bjelobaba et al., 2015).  We recently demonstrated 
that GnRH stimulus elicits an increase in histone acetylation in mature LβT2 cells (Jonak et al., 
2017), which may suggest that chromatin remodeling occurs with each pulse. Remodeling of 
chromatin that modulates gene expression occurs upon recruitment of the coactivator proteins to 
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the DNA. EGR1 interacts with SF1 and Ptx1 and forms the active transcriptional complex that 
recruits coactivator CBP. Coactivator CBP has histone acetyltransferase activity (HAT), which 
acetylates histones and leads to activation of transcription (Korzus et al., 1998). CBP is indeed 
necessary for LHβ expression and normal fertility in vivo (Miller et al., 2012). This scenario 
points to rapid changes in repression and activation of the promoter via transcriptional 
repressors, chromatin remodeling and changes in histone acetylation (Fig. 3).  
Signaling pathways triggered by GnRH receptor binding, discussed above, that activate 
gonadotropin genes transcription also induce transcription of immediate early genes. As 
demonstrated previously, GnRH induction of both gonadotropin β subunits is dependent on 
CamKII activation (Burger et al., 2008; Haisenleder et al., 2003a). We determined that GnRH 
induction of both EGR1 and cFOS immediate early genes occurs through an increase in 
intracellular calcium concentration and activation of CamKII. CamKII activity leads to 
phosphorylation of the SRF transcription factor (Ely et al., 2011). The EGR1 promoter contains 
four SRF binding sites (Witham et al., 2013), compared to the single site in the cFOS promoter 
that is responsive to GnRH (Ely et al., 2011). Higher induction of EGR1 than cFOS in response 
to GnRH may stem from four response elements in the promoter. Thus, this mechanism may be 
responsible for higher responsiveness of LHβ gene, a target of EGR1, to GnRH during the high 
pulse frequency preovulatory period, since at that time interpulse interval is not lengthy enough 
to allow immediate early gene turnover and protein degradation (Fig. 4). 
3.2. GnRH regulation of FSHβ transcription 
GnRH induces FSHβ by upregulating immediate early genes that belong to AP1 family 
of transcription factors, which subsequently bind the only site in the FSHβ promoter that conveys 
GnRH responsiveness (Coss et al., 2004). AP1 is a heterodimer of FOS and JUN transcription 
factors, which are activated rapidly and transiently by various stimuli and growth factors in 
numerous cell types (Karin et al., 1997). GnRH induces cFOS, FosB, cJUN and JunB but not 
JunD, and the combination of these factors bind the AP1 site in FSHβ promoter (Coss et al., 
2004). Transcriptome analysis revealed that AP1 members are highly induced by GnRH in LβT2 
cells (Wurmbach et al., 2001) and primary rat gonadotrope cells (Yuen et al., 2012). Similarly to 
EGR1, AP1 organizes a complex to integrate basal expression through interaction with NFY, and 
activin induction through interaction with activin-regulated SMAD3 and FOXL2 (Coss et al., 
2007; Roybal et al., 2014; Wang et al., 2008). cFOS deficient mice survive until early adulthood 
indicating possible compensation by FosB for survival, but are infertile, hypogonadotropic, and 
have similar ovarian phenotype as FSHβ knockouts, indicating necessity of cFOS for 
reproductive function (Xie et al., 2015). β-catenin may play a role in GnRH-induction of FSHβ 
expression, via its cofactor, breast cancer metastasis-suppressor 1-like (Brms1L, (Wang et al., 
2013). In vivo studies using mice with gonadotrope specific knockdown of β-catenin, mice failed 
to show the role of β-catenin in FSHβ induction. On the other hand, male mice with β-catenin 
mutant that prevents its degradation and allows for accumulation in the gonadotrope, exhibit 
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reduced FSHβ mRNA expression and diminished FSH levels due to an increase in pituitary 
follistatin expression (Boerboom et al., 2015). 
Since AP1 family members are induced by a variety of stimuli in other cell types, but are 
sufficient for activation of FSHβ transcription, it is critical to understand specificity of GnRH 
induction of immediate early genes. Analysis of pathways and transcription factors activated 
solely by GnRH to induce cJUN in gonadotrope cells, provide critical insight into GnRH 
regulation of its target gene, the gonadotropin subunit FSHβ. We determined that GnRH is the 
sole regulator of cJUN in the mature LβT2 cells, which occurs through GnRH phosphorylation 
of ATF2 transcription factor by p38, the same pathway responsible for GnRH induction of cJUN 
and FSHβ in LβT2 cells (Bonfil et al., 2004; Lindaman et al., 2013).  Of four p38 isoforms, p38β 
and p38 are sufficient for cJUN induction, demonstrating additional specificity of signaling via 
this branch (Lindaman et al., 2013). On the contrary, FSHβ induction by GnRH in primary rat 
pituitary cells does not involve p38 (Haisenleder et al., 2008), likely because cJUN component of 
the AP1 complex is present at some basal level in the gonadotrope cells, which is sufficient for 
heterodimerization with tightly regulated and highly induced cFOS. To induce cFOS, GnRH uses 
neurotransmitter-like signaling and the CamKII pathway, rather than a growth factor signaling 
via MAPK.  This provides the specificity of GnRH signaling to regulate FSHβ gene expression 
in the gonadotrope cells (Ely et al., 2011; Stojilkovic et al., 2010). The same signaling pathways 
are necessary for induction of both cFOS and FSHβ, and cFOS induction precedes that of FSHβ. 
As with EGR1 described above, GnRH induces cFOS primarily through an increase in 
intracellular calcium concentration and activation of CamKII, which then leads to 
phosphorylation of the SRF transcription factor.  The necessity for CamKII in rat pituitary 
cultures for both LHβ and FSHβ (Haisenleder et al., 2003a), may stem from CamKII 
involvement in both EGR1 and cFOS induction (Ely et al., 2011; Witham et al., 2013). Although 
receptors for several growth factors that induce cFOS in other cell lines are expressed in the 
gonadotrope, these factors are not sufficient to induce cFOS, and therefore are not involved in 
the regulation of FSHβ, likely because they do not cause an increase in intracellular calcium 
concentration that is necessary to activate CamKII and though it SRF. Presence of the single SRF 
site in the cFOS promoter, compared to four in the EGR1 promoter, may explain lower 
responsiveness of the cFOS gene than the EGR1 gene to GnRH, either when induction was 
analyzed using a reporter (Ely et al., 2011) or endogenous mRNA level (Wurmbach et al., 2001). 
Downstream, since both EGR1 and cFOS are induced rapidly and transiently, it may lead to 
lower FSHβ, a target of cFOS, than LHβ, a target of EGR1, at high pulse frequency. However, 
induction of immediate early genes does not explain higher induction of FSHβ at low pulse 
frequency. 
 To answer dependence of FSHβ expression on pulsatile GnRH, several studies analyzed 
repressors that may explain frequency responsiveness of the FSHβ promoter. Skil and Tgif1 
repressors that downregulate FSHβ induction are induced at the higher level with high pulse 
frequency, thus antagonizing cFOS (Mistry et al., 2011).  Another repressor, ICER is also 
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induced by GnRH at the high pulse frequency and binds to the AP1 site in the FSHβ promoter, 
thus repressing FSHβ expression at high pulse frequency (Ciccone et al., 2010). Importance of 
either Skil, Tgif1 or ICER has not been examined in vivo. We recently identified Jun-dimerizing 
protein 2 (JDP2) as another repressor that binds the same AP1 site and interacts with cJUN 
thereby displacing cFOS (Jonak et al., 2017). JDP2 belongs to the AP1 superfamily since it 
contains homologous DNA binding domain and the leucine zipper through which it 
heterodimerizes with cJUN, but lacks a transactivation domain to form a transcriptionally active 
complex (Aronheim et al., 1997). JDP2 is expressed at the high basal level and is not highly 
induced transcriptionally, but its repressive function may be regulated by phosphorylation (Katz 
et al., 2001). However, frequency dependence of JPD2 phosphorylation status remains to be 
explored. Consistent with a JDP2 role in FSHβ repression in the cells, female mice deficient in 
JDP2 exhibit higher expression of FSHβ, augmented FSH concentration and consequently higher 
estrogen in the circulation, and increased recruitment of ovarian follicles to the growing pool. 
JDP2 nulls also exhibit early puberty, increased litter size and cessation of reproductive function 
at younger age, implicating higher FSHβ expression to premature reproductive senescence 
(Jonak et al., 2017). Cessations of reproduction 70 days earlier in JDP2 null mouse is 
proportional to 8-year earlier menopause in women over respective reproductive lifespans. A 
complete lack of gonadotropins results in infertility in affected individuals. However, larger 
number of individuals have pathologies such as POF, with hormone levels slightly outside the 
physiological range. Since 70% of POF causes are idiopathic, repressors may provide candidates 
for investigation in affected individuals. 
Repressors may underlie the lower levels of FSHβ at high pulse frequency, but these 
findings still do not explain higher levels of FSHβ than LHβ at low pulse frequency. We 
uncovered a mechanism that may function during a period of low GnRH pulse frequency to 
extend the half-life of the cFOS protein specifically, allowing sufficient accumulation of this 
factor to increase transcription of its target gene FSHβ (Reddy et al., 2013). This leads to 
selective induction of FSH and its secondary rise, which is necessary for follicular growth. 
GnRH induces rapidly both EGR1 and cFOS, but specifically decreases the rate of cFOS 
degradation, by triggering cFOS protein phosphorylation through the ERK1/2 pathway (Fig. 4). 
Role of ERK1/2 in GnRH induction of FSHβ that has been shown in rat primary pituitary cells 
(Haisenleder et al., 1998), may stem not from direct role of ERK1/2 on FSHβ transcription, but 
from increased half-life of the cFOS protein than induces FSHβ (Reddy et al., 2013). Preferential 
activation of ERK1/2 in vivo in GnRH treated rats with low pulse frequency, also confirms its 
role in FSHβ specifically (Burger et al., 2008). Phosphorylation extends the half-life of cFOS 
protein, which is normally rapidly degraded. Confirming the role of phosphorylation in 
promoting increased protein activity, cFOS mutant which cannot be phosphorylated by GnRH 
has a shorter half-life and induces lower expression of the FHSβ promoter than wild-type, 
phosphorylatable cFOS (Reddy et al., 2013).  Our study stressed the role of post-translational 
modification in the regulation of gonadotropin gene expression by GnRH.  This modification 
may cause higher levels of FSH during the time of low GnRH pulse frequency to stimulate 
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folliculogenesis.  
 
4. Crosstalk of GnRH with other hormones that regulate gonadotropins. 
Another possible mechanism of differential regulation is interaction of GnRH signaling 
pathways and other hormones that regulate gonadotropin levels. Gonadal steroid hormones 
regulate expression of gonadotropin β subunits and pituitary responsiveness to GnRH, by 
modulating the levels of induction by GnRH-induced signaling. Pituitary responsiveness to 
GnRH is regulated by paracrine factors expressed in the pituitary itself. 
4.1. Gonadal hormones 
 Inhibin and activin are members of TGFβ superfamily. Regulation of FSH secretion is 
their initially identified and thus most studied role (Makanji et al., 2014). Inhibin decreases FSH 
secretion, while activin stimulates it. Gonads are the primary source of circulating inhibin, since 
after gonadectomy inhibin levels are undetectable. Activin, although originally purified from 
follicular fluid, has low circulating level and primarily functions in the paracrine or autocrine 
manner. Thus, activin role in gonadotropin synthesis will be discussed below. Inhibin is a 
heterodimer of α and β subunits, whereas activin is ββ homodimers. Thus, they share β subunits 
and availability of α subunit and the preferential assembly of αβ heterodimers over ββ dimers 
may be one mechanism of inhibin to antagonize activin. More likely, functional antagonism of 
activin signaling by inhibin is achieved through the competitive binding to the common receptor 
on the cell surface via the shared β subunit. Subsequently, inhibin binding prevents recruitment 
of activin signaling receptor, but instead recruits betaglycan, which prevents signaling (Chapman 
and Woodruff, 2003). Therefore, primary role of inhibin in FSH synthesis is to antagonize 
autocrine activin function. 
Although gonadal steroid hormone feedback primarily targets the hypothalamus, 
modulation of pituitary responsiveness by steroid hormones has been reported. Estrogen likely 
does not directly regulate FSHβ gene expression, but induction of LHβ gene expression by 
estrogen in gonadotropes has been reported (Shupnik et al., 1989a; Shupnik et al., 1989b). The 
mechanism may involve either ER binding to an imperfect estrogen response element in the 
distal rat LHβ promoter (Shupnik and Rosenzweig, 1991; Shupnik et al., 1989b); or ER 
recruitment to the LHβ promoter through interactions with SF1 and Ptx1 (Luo et al., 2005). 
Estrogen has been shown to potentiate GnRH induction of LHβ indirectly by enhancing the 
expression of EGR1 and suppressing the expression of ZEB, a transcriptional repressor that 
binds the rat LHβ promoter (Kowase et al., 2007). 
Progesterone and testosterone decrease LHβ expression and increase FSHβ induction 
(Thackray et al., 2009; Thackray et al., 2006; Thackray and Mellon, 2008). Testosterone and 
other androgens have been reported to repress LHβ gene expression, in both castrated, GnRH 
antagonist-treated rats (Burger et al., 2004; Wierman and Wang, 1990) and primary pituitary cell 
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culture (Winters et al., 1992). Androgens also reduced GnRH-stimulated LH section via 
alterations of calcium signaling (Ortmann et al., 1998). Androgen treatment suppressed GnRH-
induced transcription of the rat and ovine LHβ promoters, through a direct protein-protein 
interaction between the androgen receptor (AR) and Sp1 (Curtin et al., 2001), or between AR 
and SF1 (Jorgensen and Nilson, 2001), respectively. 
Both basal and GnRH-induced FSHβ mRNA levels increased in rats in vivo and in 
primary cells treated with progesterone (Attardi and Fitzgerald, 1990; Kerrigan et al., 1993). 
Progesterone antagonists blocked FSH secretion and FSHβ expression during the preovulatory 
FSH surge (Ringstrom et al., 1997) and the secondary FSH rise (Knox and Schwartz, 1992; 
Szabo et al., 1998).  Like progesterone, androgens upregulate FSHβ mRNA levels. Castrated 
GnRH antagonist-treated rats exhibited a selective increase in FSHβ mRNA upon treatment with 
testosterone (Burger et al., 2004; Dalkin et al., 1992; Paul et al., 1990; Wierman and Wang, 
1990). Suppression of LHβ and induction of FSHβ by progesterone and androgens may 
contribute to differential regulation of β-subunits. 
4.2. Autocrine and paracrine regulation by pituitary hormones  
Gonadotropes comprise 5-15% of the cells in the anterior pituitary (Ooi et al., 2004). 
Anterior pituitary contains four other types of secretory cells including thyrotropes, 
somatotropes, lactotropes and corticotropes, as well as folliculostellate cells. Many hormones 
secreted from these cells have paracrine effects on gonadotrope cells (reviewed in (Denef, 2008). 
Folliculostellate cells have been reported to rapidly overgrow other pituitary cells in culture 
(Kawakami et al., 2002) and can impact the experimental outcome since they produce paracrine 
factors such as follistatin and PACAP (reviewed in (Winters and Moore, 2007, 2011).  
PACAP was initially identified as hypothalamic factor that increases pituitary adenylate 
cyclase signaling as its name suggests. PACAP is also secreted in the pituitary by gonadotropes 
and folliculostelate cells and works in the autocrine or paracrine manner to modulate response to 
GnRH (Counis et al., 2007). GnRH increases the expression of PACAP receptor in the 
gonadotrope and in turn, PACAP potentiates the effect of GnRH on β-subunit expression likely 
via cAMP pathway crosstalk (Purwana et al., 2010). Some inconsistencies that exist in the 
literature regarding a role of PACAP in the gonadotrope, maybe due to the level or PACAP 
receptor expression in different models (Fowkes et al., 2003b). Alternatively, they can possibly 
be explained by crosstalk of pathways, since with cotreatment the pathway may be augmented, 
while pretreatment may lead to downregulation and inability to respond to a subsequent signal 
(Fowkes et al., 2003a; Larivière et al., 2008). The fact that pretreatment with either PACAP of 
GnRH diminishes the effect of the other, can likely be explained by downregulation. This 
hypothesis is strengthened by a study in which transgenic male mice with permanently elevated 
PACAP levels have delayed puberty and decreased gonadotropin levels (Moore et al., 2012).  
Prolactin from the lactotropes diminishes pituitary responsiveness to GnRH by 
decreasing LH secretion (De Paul et al., 2000; Tortonese et al., 1998). Lactotropes, which 
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comprise 20% of pituitary cells, form a honey-comb pattern in the anterior pituitary surrounding 
the gonadotropes, allowing for a close contact  and paracrine function by prolactin (Noda et al., 
2001). Gonadotropes express prolactin receptor (Tortonese et al., 1998) and prolactin has been 
shown to diminish the LH secretion and expression in response to GnRH, with no effect on basal 
levels (Garcia et al., 1985; Hodson et al., 2012; Smith, 1982).  
Follistatin is a functional antagonist of TGFβ superfamily that binds activin member of 
the family with the highest activity (Makanji et al., 2014). It binds activin at the several residues 
that are necessary for activin binding to its receptor, thus inhibiting its function. Follistatin, 
synthesized by folliculostellate cells and gonadotropes themselves, represses FSH synthesis, 
likely by antagonizing endogenous, autocrine activin (Bilezikjian et al., 2004). Follistatin also 
diminishes GnRH induction of the FSHβ gene (Coss et al., 2007), again likely due to synergistic 
effect of autocrine activin with GnRH as discussed below.  
Activin stimulates secretion of FSH and activates FSHβ transcription. Activin is 
synthesized by gonadotropes themselves and functions in the autocrine manner, while inhibin 
and follistatin, as discussed above, regulate FSH primarily by antagonizing activin. The acute 
GnRH-independent increase in FSHβ transcription after ovariectomy is due to a lack of inhibin 
to antagonize autocrine activin (Burger et al., 2001). This is true as well in younger women with 
decreased ovarian function or menopausal women that experience an increase primarily in FSH, 
as discussed as the beginning of this manuscript. Since FSH is mostly constitutively secreted, 
transcriptional regulation may be a critical regulatory step of FSH levels by activin. Activin 
functions via SMAD transcription factors and induces FSHβ transcription via SMAD3 
phosphorylation. Activin-regulated SMAD3 and 4 are necessary for FSHβ expression in vivo 
(Fortin et al., 2014a; Fortin et al., 2014b). Bernard lab (Lamba et al., 2009) and our lab (Corpuz 
et al., 2010) identified FOXL2 as a critical component in activin induction of the FSHβ gene. 
FOXL2 overexpression in gonadotropes can potentiate activin induction and its expression can 
confer activin responsiveness to FSHβ in heterologous cells where this promoter is normally 
refractory to activin induction. Mice deficient in FOXL2, both whole body knockout or 
gonadotrope-specific knockdown, have lower FSHβ level (Justice et al., 2011; Roybal et al., 
2014; Tran et al., 2013)). Various FOXL2 mutations have been identified in patients with an 
autosomal dominant disorder, BPES, which is characterized by distinctive eyelid abnormalities 
and POF (Crisponi et al., 2001; De Baere et al., 2001; De Baere et al., 2002). Considering that 
POF is caused by mutations of the FOXL2 gene, which induces FSHβ, and that this reproductive 
defect is associated with higher FSH levels in the circulation, it is intriguing to postulate again a 
role of FSH in the development of POF.  
Activin also increases pituitary responsiveness to GnRH (Coss et al., 2007; Coss et al., 
2010; Fortin et al., 2015; Gregory and Kaiser, 2004). Cotreatment of activin and GnRH results in 
the synergistic induction of FSHβ. p38 appears to be a point of crosstalk between different 
signaling pathways since it is more highly activated after GnRH and activin co-treatment of 
LβT2 cells than GnRH treatment alone (Coss et al., 2007; Zhang et al., 2006). Synergy is 
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accomplished through a complex formation of GnRH-induced AP1 and activin-regulated 
SMAD3. We showed that FOXL2, with activin-phosphorylated SMAD3, also plays a role in 
synergistic induction of FSHβ by GnRH and activin through interactions with the cJUN 
component of the AP1 complex that is necessary for GnRH responsiveness (Roybal et al., 2014). 
Another member of TGFβ family, GDF9, previously considered specifically expressed in 
oocytes is expressed in primary pituitary cultures and LβT2 cells. GDF9 is implicated in 
induction of FSHβ and synergism with GnRH, which may also contribute to differential 
expression (Choi et al., 2014). GDF9 also activates SMAD transcription factors, but whether the 
same complex plays a role in synergism with GnRH remains to be determined. The synergistic 
induction is specific for FSHβ gene and may contribute to the differential expression of the 
gonadotropin subunits. It may occur when ovarian inhibin levels decrease, allowing activin, or 
GDF9, to synergize with GnRH, at a time coinciding with the secondary peak of FSH, which is 
necessary for follicular development (Woodruff et al., 1996).  
5. Conclusion 
GnRH differentially regulates gonadotropin β-subunits expression, the limiting 
components of the mature hormone. Each pulse of GnRH induces a new wave of transcription of 
immediate early genes, EGR1 that leads to induction of LHβ, and cFOS (and more stable, but 
less regulated, cJUN) that leads to induction of FSHβ (Fig. 3 and Fig. 4).  Both EGR1 and cFOS 
have labile mRNAs and equally unstable proteins, exhibiting rapid turnover and degradation to 
allow for a tight temporal regulation of gene targets. With increasing pulse frequencies of GnRH 
in the preovulatory period, EGR1 and cFOS accumulate to overcome repressors (Nabs and JDP2 
for example, respectively) and allow expression of their respective targets. Enabled by EGR1 
and cFOS complex organizing facilities, expression of β-subunits is augmented. Due to four 
response elements in its promoter, EGR1 is induced at the higher level than cFOS leading to 
higher induction of LHβ than FSHβ with fast pulse frequency. Responsiveness to GnRH fast 
pulse frequency is likely maintained by increased receptors concentration that allows for an 
engagement of Gαs that is less susceptible to desensitization, in addition to Gαq/11. Both LHβ 
and FSHβ heterodimerize with non-limiting αGSU and are secreted under pulsatile GnRH, 
increasing their concentration in the circulation. During the low pulse frequency, specific 
phosphorylation of the cFOS protein via ERK1/2 extends its half-life, while EGR1 is degraded 
during each interpulse interval preventing accumulation. Under the endogenous activin tone, 
activin-regulated factors, such as SMAD3 and FOXL2, interact with cFOS/AP1 complex to 
synergistically induce FSHβ. FSHβ dimerizes with abundant αGSU to form a mature hormone 
that is subsequently constitutively secreted to stimulate folliculogenesis. This mechanism may 
explain preferential induction of FSHβ during the low pulse frequency of GnRH.  
The conundrum of how a single hormone, GnRH, interacting with a single receptor can 
differentially activate gonadotropin β-subunit genes in the same cell has not been answered 
completely, but significant progress has been made in our understanding of molecular 
mechanisms that regulate differential expression.  Given that pathologies such as PCOS or POF 
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may arise due to aberrations in the narrowly controlled levels, further insight is crucial to our 
understanding of regulation of reproduction at the level of the gonadotrope. Future studies may 
lead to the development of potential therapeutics for pathologies caused by dysregulation of the 
tight differential regulation.  
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Figure legends 
 
Figure 1. GnRH signaling pathways. Following binding of GnRH, GnRH receptor (GnRHR) 
primarily couples to Gαq/11 and activates PLC signaling that leads to formation of inositol 
trisphosphate (IP3) and diacylglycerol (DAG). IP3 causes an increase in the intracellular calcium 
(i-Ca) by mobilization from intracellular stores, while DAG activates PKC, which in turn leads 
to ERK1/2 MAPK activation. Calcium influx (e-Ca) occurs through voltage-gated calcium 
channels (VGCC), whose activation may involve PKC. Increase in intracellular calcium from 
either source activates CamKII, which is necessary for induction of both LHβ and FSHβ. 
Sustained increase of extracellular calcium causes higher activation of ERK1/2 and preferentially 
increase of FSHβ. 
 
Figure 2. GnRH signaling pathways that differentially regulate LHβ and FSHβ. A - Left, 
During low pulse frequency of GnRH, classical GnRH signaling, as described in Figure 1, 
activates both LHβ and FSHβ transcription. Higher activity of ERK1/2, likely caused by 
sustained influx of extracellular calcium, activates specifically FSHβ and contributes to higher 
levels of FSHβ during low pulse frequency. B - Right, During high pulse frequency of GnRH in 
proestrus, GnRHR engages Gαs in addition to Gαq/11. This may occur due to increased receptor 
concentration that is correlated with higher LHβ induction. Gαs is necessary for maximal 
induction of LHβ via unknown mechanisms, indicated with a question mark. Gαs signaling 
module is resistant to desensitization, while both IP3 receptors and DAG formation in the 
Gαq/11 signaling module desensitize with high pulse frequency. This leads to higher LHβ levels 
than FSHβ with high pulse frequency of GnRH.  
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Figure 3. Transcriptional regulation of β-subunits by GnRH. GnRH activates transcription of 
gonadotropin β-subunits via intermediates, immediate early genes; EGR1 that induces LHβ (top) 
and cFOS that induces FSHβ following heterodimerization with cJUN that forms the AP1 
transcription factor (bottom). These GnRH-induced genes organize complexes on their 
respective target gene promoters to integrate basal (Ptx1 for LHβ and NFY for FSHβ) and 
gonadotrope-specific factors (SF1). Under basal conditions (left panel), β subunit expression 
remains low due to repressors, Nab for LHβ, and JDP2 or ICER for FSHβ that recruit histone 
deacetylases (HDAC). Following EGR1 and cFOS induction by GnRH (middle panel), they 
replace Nab and JDP2 respectively, to induce β-subunit expression. Formation of the active 
transcriptional complex recruits histone acetyltransferase (HAT) to remodel histones (H). EGR1 
and cFOS have very short half-lives and are rapidly degraded. This allows repressor recruitment 
and removal of active histone marks in the promoter until the following pulse of GnRH (right 
panel). 
 
Figure 4. Differential regulation of β-subunits expression by GnRH. A – Left, During fast 
pulse frequency of GnRH in proestrus, EGR1 and cFOS accumulate to overcome repressors. 
Both EGR1 and cFOS induction by GnRH is dependent on CamKII activation of SRF 
transcription factor. Since the EGR1 promoter has four SRF response elements, compared to one 
in the cFOS promoter, EGR1 is more highly induced than cFOS, which leads to higher induction 
of LHβ than FSHβ during high pulse frequency of GnRH. B - Right, During low pulse 
frequency of GnRH, EGR1 is degraded throughout the interpulse interval due to its short half-
life. GnRH signaling via ERK1/2 specifically phosphorylates cFOS protein (indicated with “p”) 
and increases its half-life, which allows accumulation of cFOS. GnRH and activin (Act) 
synergistically induce FSHβ, indicated with “x”. GnRH-induced FOS/AP1 complex interacts 
with activin-regulated SMAD3/SMAD4/FOXL2 complex, which leads to synergistic induction 
of FSHβ and increase of FSH in the circulation during low pulse frequency of GnRH. 
 
Highlights  
 
1. Gonadotropin hormone levels are regulated by variations in GnRH pulse frequency 
2. GnRH-induced transcription of their unique β-subunits controls gonadotropin levels  
3. GnRH signaling cross-talks with gonadal and pituitary factors to regulate β-subunits 
4. GnRH induces LHβ via induction of EGR1 factor and FSHβ via induction of cFOS and cJUN 
5. Signaling pathways and factors respond differently to varied GnRH pulse frequencies  
 
 
*Highlights (for review)
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